Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7439 p179
17 February 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Bar too high for private PGDs

The burden of regulation is frustrating pharmacists who want to supply prescription medicines via private patient group directions, according to the National Pharmacy Association.

“Currently, [regulations] require registration with the Health Care Commission and the involvement of a medical agency when wishing to set up a private PGD service. This is on top of current mandatory regulation of all pharmacies and pharmacists by the Royal Pharmaceutical Society, not to mention additional oversight [by primary care organisations] required through the NHS contractual framework,” the NPA said in a statement issued this week. It added that regulatory streamlining could be done without adversely affecting patient safety.

An NPA spokesman commented: “The process of registration is time consuming and costly, effectively [excluding] some providers. NPA members are telling us that when they try to innovate using this route they are stymied at the first hurdle. The Government has committed to reduce the burden of regulation across all of their departments; we look forward to discussing a way forward with officials.”

He added: “At a time of NHS deficits, there is an opportunity to equip pharmacists with an alternative method of medicine supply, further encouraging self care.”

Back to Top


©The Pharmaceutical Journal